Compare ARK Genomic Revolution ETF (ARKG) vs JPMorgan Ultra Short Income ETF (JPST) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs JPMorgan Ultra Short Income ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while JPMorgan Ultra Short Income ETF trades at $50.44. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, JPMorgan Ultra Short Income ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | JPST | |
|---|---|---|
Sector | Sector/Thematic | Leveraged / Inverse |
52-Week High | $43.57 | $50.78 |
52-Week Low | $23.09 | $50.40 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
JPST, the JPMorgan Ultra-Short Income ETF, trades at $50.45 with no recent price change. The technical outlook is bearish based on moving averages, while oscillators are neutral. The fund focuses on high-quality, short-term bonds, offering a cash alternative with low duration risk. Recent news highlights its role in rising rate environments and strong flows into active ETFs.
The outlook for JPST is stable, appealing to risk-averse investors seeking income and capital preservation amid interest rate uncertainty. Key risks include interest rate sensitivity and credit spread changes. Institutional interest is growing, but the bearish technical signal warrants caution for short-term traders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About JPMorgan Ultra Short Income ETF
JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →
